Advertisement

Ads Placeholder
Loading...

BioMark Diagnostics Inc.

BMKDF•PNK
Healthcare
Medical - Diagnostics & Research
$0.44
$0.00(0.00%)
U.S. Market opens in 57h 56m

BioMark Diagnostics Inc. (BMKDF) Stock Overview

Explore BioMark Diagnostics Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap45.9M
P/E Ratio-37.67
EPS (TTM)$-0.01
ROE-1.53%
Fundamental Analysis

AI Price Forecasts

1 Month$0.43
3 Months$0.48
1 Year Target$0.41

BMKDF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BioMark Diagnostics Inc. (BMKDF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 56.97, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.41.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -37.67 and a market capitalization of 45.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
15.74%
3-Month Change
27.38%
6-Month Change
103.16%
Year-to-Date (YTD) Change
27.38%
1-Year Change
136.11%
3-Year Change
191.20%
5-Year Change
26.50%
All-Time (Max) Change
26.61%

Contact Information

https://www.biomarkdiagnostics.com
604 370 0779
3851 Shell Road, Richmond, BC, V6X 2W2

Company Facts

IPO DateMar 23, 2015
CountryCA
Actively Trading

Frequently Asked Questions